SCHOTT MINIFAB
James Downs currently serves as the VP of Business Development for the USA at SCHOTT MINIFAB, where responsibilities include leading market and project development for the medical diagnostics division. Previous roles include Director of Global Business Development at Schott AG, University Lecturer at HHL Leipzig Graduate School of Management, and Adjunct Professor at Northeastern University. James founded J.B. Downs & Co., a life science-focused consultancy, and directed business development for biotech research at Leipzig University. Prior experience at Pfizer included management of a $31 million district and recognition within the top 10% of sales performance. James holds a Doctorate in Economics from HHL Leipzig Graduate School of Management, along with an MBA in International Management and a BSBA in International Business.
This person is not in any teams
This person is not in any offices
SCHOTT MINIFAB
1 followers
SCHOTT MINIFAB is ISO 9001 & ISO 13485 certified, offering contract design, development and manufacturing of microfluidic consumables and high-density microarrays for diagnostic and life science research. Enabling product developers to get their innovation to market faster and more efficiently. We partner with IVD developers and other biotech clients to deliver commercially successful microfluidic devices from early-stage development through to high-volume manufacture. As a fully integrated manufacturer, we provide multidisciplinary expertise across materials, engineering, bioscience, and automation in order to manufacturer components or the entire consumable device. Our purpose-built capabilities help our clients overcome complex challenges on their path to commercialization, allowing them to reach the market faster and more efficiently. With three Centers of Excellence, located in Australia, Europe and North America, we can support product developers in all parts of the world. Throughout our 20-year history, we have delivered thousands of successful projects for our clients. We continue to pioneer new advancements in point-of-care diagnostics, clinical diagnostics, high-density microarray research. Fulfilling the need for a full-service solutions provider for microfluidic consumable devices, from development to manufacture with in-house manufacturing and bioscience expertise.